Literature DB >> 17093206

Mitogenic signal transduction caused by monomethylarsonous acid in human bladder cells: role in arsenic-induced carcinogenesis.

Kylee E Eblin1, Tiffany G Bredfeldt, Sarah Buffington, A Jay Gandolfi.   

Abstract

Previous studies have shown that human bladder cells (UROtsa), a target of arsenic-induced cancer, can biotransform arsenite to monomethylarsonous acid (MMA(III)), which is more cytotoxic and capable of transforming the UROtsa cells following long-term, low-level exposure. Cyclooxygenase-2 (COX-2) causes hyperplasia in bladder cells and is considered a key biomarker in bladder cancer. To investigate the role of mitogenic pathway stimulation in MMA(III)-induced transformation, UROtsa cells were treated with 50nM MMA(III) for 12, 24, or 52 weeks and analyzed by Western blot for COX-2 expression. Elevations in COX-2 expression were noted following chronic MMA(III) exposure, and this induction increased with duration of exposure, suggesting that COX-2 or the signal transduction pathways responsible for COX-2 protein expression may play a role in MMA(III)-induced transformation. Acute exposure studies found MMA(III) treatment (10, 50, and 100nM, 4 h) induced COX-2 in UROtsa cells with the lowest doses (10 and 50nM) causing the strongest induction. Using pharmacological inhibitors of various pathways, it was shown that epidermal growth factor receptor (EGFR), extracellular signal-regulated kinase (ERK-1/-2), phosphoinositide 3-kinase (PI3K), and src were important in the induction of COX-2 by MMA(III). ERK-2 phosphorylation was verified by Western blot analysis with a peak at 15 min, and c-jun was translocated to the nucleus following 50nM MMA(III) treatment. To determine MMA(III) targets, receptors of the erythroblastosis oncogene family (ErbB) family were further investigated. Chronic MMA(III) exposure led to upregulation of the EGFR or ErbB1. Short-term MMA(III) treatment caused the phosphorylation of ErbB2 in its autophosphorylation site. To verify the importance of these signaling pathways to the growth of the MMA(III)-transformed UROtsa cells in soft agar, various inhibitors were used to block pathways and monitor cells growth. Pathways of importance in anchorage-independent growth of UROtsa cells chronically exposed to MMA(III) are src, PI3K, and COX-1 and -2. As COX-2 is an important mediator that contributes to carcinogenesis via promotion of cell proliferation, inhibition of cell death, induction of angiogenesis, and facilitation of invasion, and it is highly upregulated both acutely and chronically in the MMA(III)-transformed cells, it is likely that activation of the mitogen-activated protein kinase pathway and increased COX-2 expression is a plausible mechanism for MMA(III) bladder carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17093206     DOI: 10.1093/toxsci/kfl160

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  28 in total

1.  An EGFR-ERK-SOX9 signaling cascade links urothelial development and regeneration to cancer.

Authors:  Shizhang Ling; Xiaofei Chang; Luciana Schultz; Thomas K Lee; Alcides Chaux; Luigi Marchionni; George J Netto; David Sidransky; David M Berman
Journal:  Cancer Res       Date:  2011-04-21       Impact factor: 12.701

Review 2.  Influence of arsenate and arsenite on signal transduction pathways: an update.

Authors:  Ingrid L Druwe; Richard R Vaillancourt
Journal:  Arch Toxicol       Date:  2010-05-26       Impact factor: 5.153

3.  Low-level arsenic causes proteotoxic stress and not oxidative stress.

Authors:  Matthew Dodson; Montserrat Rojo de la Vega; Bryan Harder; Raul Castro-Portuguez; Silvia D Rodrigues; Pak Kin Wong; Eli Chapman; Donna D Zhang
Journal:  Toxicol Appl Pharmacol       Date:  2018-02-03       Impact factor: 4.219

4.  ATF2 partly mediated the expressions of proliferative factors and inhibited pro-inflammatory factors' secretion in arsenite-treated human uroepithelial cells.

Authors:  Shengnan Liu; Fei Wang; Jieyu Liu; Peiyu Jin; Xiaoyan Wang; Li Yang; Shuhua Xi
Journal:  Toxicol Res (Camb)       Date:  2017-03-29       Impact factor: 3.524

5.  Global gene expression changes in human urothelial cells exposed to low-level monomethylarsonous acid.

Authors:  Matthew Medeiros; Xinghui Zheng; Petr Novak; Shawn M Wnek; Vivian Chyan; Claudia Escudero-Lourdes; A Jay Gandolfi
Journal:  Toxicology       Date:  2011-11-17       Impact factor: 4.221

6.  Genetic association between intronic variants in AS3MT and arsenic methylation efficiency is focused on a large linkage disequilibrium cluster in chromosome 10.

Authors:  Paulina Gomez-Rubio; Maria M Meza-Montenegro; Ernesto Cantu-Soto; Walter T Klimecki
Journal:  J Appl Toxicol       Date:  2010-04       Impact factor: 3.446

7.  Transcriptional Modulation of the ERK1/2 MAPK and NF-κB Pathways in Human Urothelial Cells After Trivalent Arsenical Exposure: Implications for Urinary Bladder Cancer.

Authors:  Kathryn A Bailey; Kathleen Wallace; Lisa Smeester; Sheau-Fung Thai; Douglas C Wolf; Stephen W Edwards; Rebecca C Fry
Journal:  J Can Res Updates       Date:  2012-08-21

8.  The role of reactive oxygen species in arsenite and monomethylarsonous acid-induced signal transduction in human bladder cells: acute studies.

Authors:  K E Eblin; A M Hau; T J Jensen; B W Futscher; A J Gandolfi
Journal:  Toxicology       Date:  2008-06-05       Impact factor: 4.221

9.  Persistence of DNA damage following exposure of human bladder cells to chronic monomethylarsonous acid.

Authors:  S M Wnek; M K Medeiros; K E Eblin; A J Gandolfi
Journal:  Toxicol Appl Pharmacol       Date:  2009-08-20       Impact factor: 4.219

10.  Exposure to monomethylarsonous acid (MMA(III)) leads to altered selenoprotein synthesis in a primary human lung cell model.

Authors:  Sarah R Meno; Rebecca Nelson; Korry J Hintze; William T Self
Journal:  Toxicol Appl Pharmacol       Date:  2008-11-27       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.